Abstract

Functional hyperemia occurs when enhanced neuronal activity signals to increase local cerebral blood flow (CBF) to satisfy regional energy demand. Ca2+ elevation in astrocytes can drive arteriole dilation to increase CBF, yet affirmative evidence for the necessity of astrocytes in functional hyperemia in vivo is lacking. In awake mice, we discovered that functional hyperemia is bimodal with a distinct early and late component whereby arteriole dilation progresses as sensory stimulation is sustained. Clamping astrocyte Ca2+ signaling in vivo by expressing a plasma membrane Ca2+ ATPase (CalEx) reduces sustained but not brief sensory-evoked arteriole dilation. Elevating astrocyte free Ca2+ using chemogenetics selectively augments sustained hyperemia. Antagonizing NMDA-receptors or epoxyeicosatrienoic acid production reduces only the late component of functional hyperemia, leaving brief increases in CBF to sensory stimulation intact. We propose that a fundamental role of astrocyte Ca2+ is to amplify functional hyperemia when neuronal activation is prolonged.

Neuronal activity increases local cerebral blood flow (CBF) to satisfy metabolic demand, yet the role of astrocytes in this phenomenon is controversial. Here, the authors show that astrocytes amplify CBF only when neuronal activity is sustained.

Details

Title
Astrocytes amplify neurovascular coupling to sustained activation of neocortex in awake mice
Author
Institoris, Adam 1   VIAFID ORCID Logo  ; Vandal, Milène 1 ; Peringod, Govind 1 ; Catalano, Christy 1 ; Tran, Cam Ha 2 ; Yu, Xinzhu 3   VIAFID ORCID Logo  ; Visser, Frank 1 ; Breiteneder, Cheryl 1 ; Molina, Leonardo 4 ; Khakh, Baljit S. 5 ; Nguyen, Minh Dang 4 ; Thompson, Roger J. 6 ; Gordon, Grant R. 1   VIAFID ORCID Logo 

 University of Calgary, Hotchkiss Brain Institute, Department of Physiology and Pharmacology, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 University of Calgary, Hotchkiss Brain Institute, Department of Physiology and Pharmacology, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Nevada, Department of Physiology and Cell Biology, Reno School of Medicine, Reno, USA (GRID:grid.266818.3) (ISNI:0000 0004 1936 914X) 
 University of California Los Angeles, Department of Physiology, David Geffen School of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California Los Angeles, Department of Neurobiology, David Geffen School of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of Illinois Urbana-Champaign, Department of Molecular and Integrative Physiology, Beckman Institute, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991) 
 University of Calgary, Hotchkiss Brain Institute, Department of Clinical Neuroscience, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 University of California Los Angeles, Department of Physiology, David Geffen School of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California Los Angeles, Department of Neurobiology, David Geffen School of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718) 
 University of Calgary, Hotchkiss Brain Institute, Department of Cell Biology and Anatomy, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
Pages
7872
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2756863709
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.